Board of Trustees
Chad Rubin is a Managing Director for the Trout Group and Trout Capital. Trout is the leading investor relations and capital markets advisory firm dedicated to the life science industry. Chad has over 16 years of experience advising management teams in the sector. Prior to joining Trout’s team in 2005 Chad was the head of Biotechnology Capital Markets Intelligence Group at Thomson Financial, assisting over 100 life sciences companies in their understanding of Wall Street. He brings with him experience in advising life science companies on topics including company creation, seed funding, shareholder targeting, capital markets transactions, message crafting and scenario analysis. His experience includes work in finance, consulting and market analysis. He has been involved with companies from the pre-IPO stages to follow-on and convertible offerings. He is involved in capital transactions with corporate clients and has counseled clients on domestic and cross-border transactions and binary data events.
Chad holds a Bachelor of Arts degree in business administration with a concentration in finance from Franklin & Marshall College. He has a minor in film and media studies. He also holds Series 7, 79 and 63 securities licenses.
Chad began volunteering with the Histiocytosis Association in 2008 after his son, Jack, was diagnosed with Langerhans cell histiocytosis and secondary HLH. Jack and Chad's wife, Kristy, lived at Children's Hospital of Philadelphia for over 19 months fighting the diseases. Jack was cured with a bone marrow transplant and is a healthy boy today! Histiocytosis Association provided Chad with support, information and resources to help his family fight and beat the horrible disease. Chad and Kristy founded the annual fundraiser "All Jacked Up" in 2009. Together with friends and family they have raised over $500,000 to help find a cure.